✦ LIBER ✦

A fixed-dose phase I study of ZD9331, a novel non-polyglutamated inhibitor of thymidylate synthase, in patients with refractory cancer

✍ Scribed by Bertucci, D.; Ratain, M.J.; Smith, R.; Mani, S.; Vogelzang, N.J.; Schilsky, R.L.; Goh, B.C.; Smith, M.; Douglass, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacokinetic study of t

✍ Garry H. Schwartz; Christopher B. Jones; Mitchell Garrison; Amita Patnaik; Chris 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 145 KB

A phase I, dose-escalation study of the

✍ J.P. Stevenson; K. Algazy; K. McLaughlin; D.G. Haller; B.J. Giantonio; M. Koehle 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Phase I study of AG 331, a novel thymidy

✍ Robert T. Koda; Agustin A. Garcia; Dhruba J. Chatterjee; Wen Yen Li; Deepika Par 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 153 KB

Synergistic effects of ZD9331 a non-poly

✍ Raymond, E.; Louvet, C.; Coudray, A.M.; Faivre, S.; Gespach, C. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 130 KB

A phase I and pharmacokinetic study of O

✍ A. R. Clamp; P. Schöffski; J. W. Valle; R. H. Wilson; S. Marreaud; A.-S. Govaert 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 315 KB

Phase I–II study of high-dose etoposide

✍ Giuseppe Fraschini; Frankie A. Holmes; Laura Esparza; Richard L. Theriault; Aman 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 162 KB